Journal ArticleAnn Vasc Surg · December 2025
BACKGROUND: The Hemodialysis Reliable Outflow (HeRO) graft combines an arteriovenous graft with a central venous stent, allowing for hemodialysis access in patients with end-stage renal disease limited by central venous stenosis. The impact of anticoagulat ...
Full textLink to itemCite
Journal ArticleJ Vasc Surg · December 2025
BACKGROUND: Hemodialysis Reliable Outflow (HeRO) graft implantation is performed as a last resort option for hemodialysis access in patients limited by central venous stenosis or occlusion. In this single-center series, we examined the incidence, risk fact ...
Full textLink to itemCite
Journal ArticleJ Surg Res · November 2025
INTRODUCTION: Asians are considered an over-represented minority in medicine, making up 7% of the US national population but 17.1% of active physicians. However, representation trends are different across surgical specialties, and many surgical residency p ...
Full textLink to itemCite
Journal ArticleAnn Vasc Surg · October 15, 2025
BACKGROUND: Vascular surgeons are essential to maintaining a safe operating room environment for all surgical specialties, in addition to managing primary vascular diseases. The value of the vascular surgery service line within a health-care system has bee ...
Full textLink to itemCite
Journal ArticleJ Vasc Surg · October 2025
OBJECTIVE: The Hemodialysis Reliable Outflow (HeRO) graft offers hemodialysis access options for patients who have developed central venous stenosis or occlusion. In this single-center study, we report our perioperative and long-term outcomes after HeRO gr ...
Full textLink to itemCite
Journal ArticleAnn Vasc Surg · January 2025
BACKGROUND: Current practice guidelines recommend dual antiplatelet therapy for at least 30 days postoperatively after transcarotid artery revascularization (TCAR) to promote stent patency. However, many patients are already taking other antithrombotic med ...
Full textLink to itemCite
Journal ArticleSemin Vasc Surg · December 2024
Hemodialysis (HD) access failure is a frequent problem encountered by vascular surgeons. As treatment of end-stage renal disease improves and patients live longer on HD, eventual exhaustion of traditional upper extremity HD access is common. Efforts to pre ...
Full textLink to itemCite
Journal ArticleJ Surg Res · August 2024
INTRODUCTION: A dysregulated immune system is a major driver of the mortality and long-term morbidity from sepsis. With respect to macrophages, it has been shown that phenotypic changes are critical to effector function in response to acute infections, inc ...
Full textLink to itemCite
Journal ArticleJ Vasc Surg Venous Lymphat Disord · November 2022
OBJECTIVE: Management of Paget-Schroetter syndrome (PSS) with first rib resection (FRR) and venoplasty is successful in re-establishing subclavian vein (SCV) patency in most cases. However, in cases with subacute or chronic venous occlusion, SCV patency ma ...
Full textLink to itemCite
Journal ArticleJ Vasc Surg · September 2022
INTRODUCTION: Most patients with acute Paget-Schroetter syndrome (PSS) present in one of two manners: (1) thrombosis managed initially with thrombolysis and anticoagulation and then referred for surgery, and (2) initial treatment with anticoagulation only ...
Full textLink to itemCite
Journal ArticleAnn Vasc Surg · July 2022
OBJECTIVES: Congenital abnormalities of the first rib (ABNFR) are a rare cause of thoracic outlet syndrome (TOS). The range of abnormalities have not been clearly documented in the literature. Surgical decompression in these patients presents with increase ...
Full textLink to itemCite
Journal ArticleJ Vasc Surg Venous Lymphat Disord · July 2021
OBJECTIVE: Thrombus extension into the deep venous system following superficial vein chemical ablation with Varithena polidocanol microfoam has been reported. The objective of this study was to assess the effect of intraoperative improved techniques during ...
Full textLink to itemCite
Journal ArticleJournal of Vascular Surgery Cases and Innovative Techniques · December 1, 2020
Patients with acute coronavirus disease 2019 (COVID-19) respiratory infection are associated with concomitant thromboembolic complications and a hypercoagulable state. Although these mechanisms are not completely understood, unique alterations in the serum ...
Full textCite
Journal ArticleJ Vasc Surg · October 2020
OBJECTIVE: During the COVID-19 pandemic, central venous access line teams were implemented at many hospitals throughout the world to provide access for critically ill patients. The objective of this study was to describe the structure, practice patterns, a ...
Full textLink to itemCite
Journal ArticleAm J Physiol Gastrointest Liver Physiol · January 1, 2019
The liver is an organ that, when dysfunctional in a septic patient, is strongly associated with morbidity and mortality. Understanding the pathophysiology of liver failure during sepsis may lead to improved diagnostics and potential therapeutic targets. Hi ...
Full textLink to itemCite
Journal ArticleAm J Pathol · September 2018
Sepsis remains a major public health concern, characterized by marked immune dysfunction. Innate lymphoid cells develop from a common lymphoid precursor but have a role in orchestrating inflammation during innate response to infection. Here, we investigate ...
Full textLink to itemCite
Journal ArticleFrontiers in Immunology · November 20, 2017
We have shown that invariant natural killer T (iNKT) cells mediate sepsis-induced end-organ changes and immune responses, including macrophage bacterial phagocytosis, a finding regulated by the check point protein program cell death receptor-1 (PD-1). Furt ...
Full textCite
Chapter · May 29, 2017
This book is designed to provide a comprehensive and state-of-the-art resource for clinicians who care for patients with sepsis and research scientist alike, . ...
Cite
Journal ArticleAnn Vasc Surg · May 2017
BACKGROUND: Despite advances in perioperative care, the rate of cardiac events in vascular patients remains high. We have previously shown that infections in trauma patients are associated with higher rates of subsequent cardiac complications, likely due t ...
Full textLink to itemCite
Journal ArticleEur J Nucl Med Mol Imaging · June 2013
PURPOSE: We investigated the metabolic response of lung cancer to radiotherapy or chemoradiotherapy by (18)F-FDG PET and its utility in guiding timely supplementary therapy. METHODS: Glucose metabolic rate (MRglc) was measured in primary lung cancers durin ...
Full textLink to itemCite